Ethosuximide Suppliers & Bulk Manufacturers
Available Forms: Capsules / Oral Solution
Available Strengths: 250mg, 250mg/5ml
Reference Brands: Zarontin (USA)
Category:
Neurology
Ethosuximide is an anticonvulsant medication belonging to the succinimide class. It is primarily used to treat absence seizures, particularly in children. Ethosuximide works by inhibiting T-type calcium channels in the thalamus, which are believed to play a key role in generating the abnormal electrical activity associated with absence seizures.
Ethosuximide is available in Capsules / Oral Solution
and strengths such as 250mg, 250mg/5ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ethosuximide is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ethosuximide can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing